Patient-Centric Health Care
From diagnoses to treatment for both primary and specialty care, the patient and provider experience is undergoing a dramatic shift. Innovations and policies are repaving the patient journey. 2024 will see further advancements that embed new practices and paradigms.
What we’re watching
Beyond pills to durable, lasting treatment benefits
- Synthetic biology technologies
- Disease diagnosis shifting from clunky scans to blood-based assays
- Gene and cell therapies at commercial scale
- FDA accelerated approval pathway
- Liquid biopsy
- Continued shifts in sites of care
- Drug pricing
These new treatments are achieving commercial success, with multiple classes of newer modalities surpassing >$1 billion in annual sales per product.